The Lancet Gastroenterology & Hepatology in conversation with
Podcast autorstwa The Lancet Group
84 Odcinki
-
Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
Opublikowany: 10.01.2025 -
Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures
Opublikowany: 12.12.2024 -
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
Opublikowany: 6.11.2024 -
Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease
Opublikowany: 1.11.2024 -
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer
Opublikowany: 31.07.2024 -
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
Opublikowany: 1.07.2024 -
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
Opublikowany: 17.05.2024 -
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease
Opublikowany: 7.05.2024 -
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa
Opublikowany: 22.04.2024 -
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
Opublikowany: 12.03.2024 -
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity
Opublikowany: 1.03.2024 -
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
Opublikowany: 19.12.2023 -
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
Opublikowany: 29.11.2023 -
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease
Opublikowany: 12.10.2023 -
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction
Opublikowany: 13.09.2023 -
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
Opublikowany: 10.08.2023 -
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
Opublikowany: 12.07.2023 -
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
Opublikowany: 7.06.2023 -
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
Opublikowany: 10.05.2023 -
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Opublikowany: 12.04.2023
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.